Health Highlights: July 2, 2018

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Court Blocks Kentucky’s Medicaid Work Rules Kentucky’s plan to require many Medicaid recipients to work, get job training or volunteer has been blocked by a federal judge. The Trump administration’s approval of the plan was “arbitrary and capricious” […]

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson. Can-Fite extensively published that its anti-cancer drug candidate, Namodenoson, inhibits a […]

Abcam collaborates with Merck to produce anti-PD-L1 antibody clone for global research community

Clone 73-10 now available to the global research community Abcam, a global innovator in life science reagents and tools today announced the commercial launch of the new anti-PD-L1 antibody clone MKP1A07310 (clone 73-10) developed in collaboration with Merck KGaA, Darmstadt, Germany. Developed by Abcam for use by Merck as an analytical antibody to support Merck’s […]

Researchers discover gene that plays role in regulating body’s immune response to infection

Australia’s national science agency CSIRO has identified a new gene that plays a critical role in regulating the body’s immune response to infection and disease. The discovery could lead to the development of new treatments for influenza, arthritis and even cancer. The gene, called C6orf106 or “C6”, controls the production of proteins involved in infectious […]